Literature DB >> 30265167

The NMBU FIGARO low dose irradiation facility.

Ole Christian Lind1, Deborah Helen Oughton1, Brit Salbu1.   

Abstract

PURPOSE: Derivation of dose-response relationships for exposed organisms and their sensitive life history stages requires in-house experiments under well-defined, controlled conditions. In the present work we describe the FIGARO low dose gamma irradiation facility at the Norwegian University of Life Sciences, Ås, Norway, which is managed by the Centre of Environmental Radioactivity (CERAD CoE).
CONCLUSIONS: The CERAD/NMBU facility opened in 2003, and was upgraded to a climate controlled facility in 2012, supported by the EU DoReMi project. The 60Co irradiation source provides a continuous dose rate field from 3 Gy/hr down to 0.4 mGy/hr when maximally loaded (400 GBq). The FIGARO low dose gamma irradiation facility allows simultaneous acute to chronic exposure of organisms over the whole dose-rate field. The facility is licensed for a number of different test organisms, including GMOs, and can be used in combination with other stressors such as trace metals and UV radiation.

Entities:  

Keywords:  Gamma irradiation facility; a series of test organisms; multiple stressor exposures; radiobiology; radioecology

Mesh:

Substances:

Year:  2018        PMID: 30265167     DOI: 10.1080/09553002.2018.1516906

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  2 in total

1.  Changes in Growth, Morphology, and Physiology of Tetrahymena pyriformis Exposed to Continuous Cesium-137 and Cobalt-60 Gamma-Radiation.

Authors:  Soukaina Ziyadi; Abdelghani Iddar; Mostafa Kabine; Mohammed El Mzibri; Adnane Moutaouakkil
Journal:  Curr Microbiol       Date:  2022-01-04       Impact factor: 2.188

2.  VADER: a variable dose-rate external 137Cs irradiator for internal emitter and low dose rate studies.

Authors:  Guy Garty; Yanping Xu; Gary W Johnson; Lubomir B Smilenov; Simon K Joseph; Monica Pujol-Canadell; Helen C Turner; Shanaz A Ghandhi; Qi Wang; Rompin Shih; Robert C Morton; David E Cuniberti; Shad R Morton; Carlos Bueno-Beti; Thomas L Morgan; Peter F Caracappa; Evagelia C Laiakis; Albert J Fornace; Sally A Amundson; David J Brenner
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.